WO2007100575A2 - Method for patterning a medical device - Google Patents
Method for patterning a medical device Download PDFInfo
- Publication number
- WO2007100575A2 WO2007100575A2 PCT/US2007/004478 US2007004478W WO2007100575A2 WO 2007100575 A2 WO2007100575 A2 WO 2007100575A2 US 2007004478 W US2007004478 W US 2007004478W WO 2007100575 A2 WO2007100575 A2 WO 2007100575A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medical device
- applying
- treating
- masking agent
- color
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/92—Identification means for patients or instruments, e.g. tags coded with colour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/94—Identification means for patients or instruments, e.g. tags coded with symbols, e.g. text
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q9/00—Arrangements in telecontrol or telemetry systems for selectively calling a substation from a main station, in which substation desired apparatus is selected for applying a control signal thereto or for obtaining measured values therefrom
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2209/00—Arrangements in telecontrol or telemetry systems
- H04Q2209/10—Arrangements in telecontrol or telemetry systems using a centralized architecture
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04Q—SELECTING
- H04Q2209/00—Arrangements in telecontrol or telemetry systems
- H04Q2209/40—Arrangements in telecontrol or telemetry systems using a wireless architecture
- H04Q2209/43—Arrangements in telecontrol or telemetry systems using a wireless architecture using wireless personal area networks [WPAN], e.g. 802.15, 802.15.1, 802.15.4, Bluetooth or ZigBee
Definitions
- the present disclosure relates to a method for patterning a medical device, and more particularly, a method for color-patterning a dyed medical device, such as a suture.
- a medical device such as a suture
- methods for coloring a medical device may be utilized to enhance their visibility during laparoscopic procedures.
- colored sutures allow for immediate brand recognition by the personnel that use the suture material, i.e., doctors, nurses, and other surgical team members.
- U.S. Pat. No. 4,008,303 discloses a method of coloring polyglycolic acid surgical elements by incorporating l,4-bis(p-toluidino)-anthraquinone into molten polyglycolic acid to form pellets which may then be spun to form green filaments.
- U.S. Pat. No. 5,312,437 discloses a method for forming a dyed braid by dry blending a colorant with a non-absosrbable resin to form a blend and extruding the blend to form filaments which may be braided to form sutures.
- the methods include the steps of applying at least one volatile dye to a medical device, applying at least one masking agent to predetermined portions of the dyed medical device, and treating the masked, dyed medical device to remove the at least one volatile dye to thereby form a colored pattern on the medical device.
- the present methods can be used to form color patterns on any medial device.
- the color pattern on the medical device may improve visualization of the device during implantation or use in a patient.
- Some examples of medical devices which may be treated in accordance with the present disclosure include, but are not limited to, sutures, staples, meshes, patches, slings, stents, grafts, clips, pins, screws, rivets, tacks, bone plates, drug delivery devices, wound dressings, woven devices, non-woven devices, braided devices, adhesion barriers, tissue scaffolds, and other implants.
- the medical device can be formed from any material that has suitable physical properties for the intended use of the medical device. Medical devices can thus be formed of absorbable materials, nonabsorbable materials, and combinations thereof. Suitable absorbable materials which may be utilized to form the medical device include trimethylene carbonate, caprolactone, dioxanone, glycolic acid, lactic acid, glycolide, lactide, homopolymers thereof, copolymers thereof, and combinations thereof. Suitable non-absorbable materials which may be utilized to form the medical device include polyolefins, such as polyethylene, polypropylene, copolymers of polyethylene and polypropylene, and blends of polyethylene and polypropylene. In embodiments, the medical device can be sterilized.
- the medical device may be a suture.
- Suitable absorbable materials which may be utilized for sutures include polyesters such as glycolide, caprolactone, trimethylene carbonate, lactide, and various combinations thereof.
- Examples of sutures made of such materials include those commercially available and sold under the name POLYSORB ® , CAPROSYN ® , BIOSYN ® , SURGIPRO ® and VASCUSIL ® .
- the medical device may be formed from one or more filaments. Where formed of more than one filament, the filaments can be knitted, braided, woven or non-woven.
- the methods for patterning a medical device disclosed herein include the following steps: applying at least one volatile dye to a medical device; applying at least one masking agent to the dyed medical device; and treating the masked, dyed medical device to form a color pattern on the medical device.
- a volatile dye may include, for example, any dye, color or pigment capable of being selectively removed from the bulk material of a given medical device when exposed to the treatment processes described herein.
- volatile dyes include, but are not limited to Color Index (CI.) No. 74160 (copper phthalocyanine, [phthalocyaninato (2-)] copper, also referred to as copper tetrabenzoporphyrazine or tetrabenzo-5,10,15,20-diazaporphyrinephthalocyanine); C.I. No. 61565 (D&C Green No. 6 (principally l,4-bis[(4-methylphenyl)amino]-9,10-anthracenedione)); C.I. No.
- the dye may be an FDA- approved dye which may be employable in medical devices, including sutures.
- the at least one volatile dye may be D&C Violet Number 2.
- the present methods described herein also utilize at least one masking agent in patterning a medical device.
- the at least one masking agent may include any agent able to prevent or hinder the extraction of the at least one volatile dye from the medical device during the treatment processes described herein.
- Suitable masking agents include, but are not limited to, metal salts of fatty acids.
- Examples of fatty acids useful for forming a metal salt of a fatty acid useful herein includes butyric, caproic, caprylic, capric, lauric, myristic, palmitic, palmitoleic, stearic, oleic, linoleic, linolenic, etc.
- Examples of monovalent metals useful for forming a metal salt of a fatty acid useful in the various embodiments described herein include lithium, rubidium, cesium, francium, copper, silver and gold.
- Examples of polyvalent metals useful for forming a metal salt of a fatty acid useful in the various embodiments described herein include calcium, magnesium, beryllium, aluminum, tin, lead, bismuth and the polyvalent transition metals.
- Some examples of useful masking agents include, but are not limited to, calcium stearate, magnesium stearate, barium stearate, aluminum stearate, zinc stearate, calcium palmitate, magnesium palmitate, barium palmitate, aluminum palmitate, zinc palmitate., calcium oleate, magnesium oleate, barium oleate, aluminum oleate, and zinc oleate.
- the at least one masking agent is calcium stearate.
- the volatile dye and/or the at least one masking agent may be combined with any polymer or other suitable material utilized to form the medical device prior to forming the medical device, thereby incorporating the volatile dye and/or the at least one masking agent into the medical device.
- a dye may be added to a polymer utilized to form a suture after polymerization, but prior to extrusion.
- the at least one masking agent and/or the volatile dye may be applied to the surface of the medical device either simultaneously or sequentially, for example, the dye may first be applied to the surface of the medical device followed by application of the masking agent. Combinations of these treatments may also be used, for example, the volatile dye may be combined with a polymer utilized to form a medical device while the at least one masking agent may be applied as a coating on the dyed medical device.
- the at least one masking agent can be applied to the medical device in any amount sufficient to form the desired color pattern.
- the amount of the at least one masking agent in the dyed medical device may be from about 0.01% to about 10 % by weight of the medical device, in embodiments from about 0.1% to about 5 %, in other embodiments from about 0.5 % to about 2.5 % by weight of the medical device.
- the masking agent may be combined with any polymer within the purview of those skilled in the art and applied as a coating to the medical device.
- Suitable polymers include bioabsorbable polymers such as polylactic acid, polyglycolic acid, polydioxanone, polycapro lactone, copolymers of glycolide and trimethylene carbonate, polylactide/polyglycolide copolymers, polyesteramides, trimethylene carbonate, tetramethylene carbonate, dimethyl trimethylene carbonate, dioxanones, dioxepanones, absorbable cyclic amides, absorbable cyclic ether-esters derived from crown ethers, beta hydroxyacids (such as beta hydroxybutyric acid and gamma hydroxyvaleric acid), polyalkyl ethers (such as polyethylene glycol and polylpropylene glycol) and combinations thereof.
- bioabsorbable polymers such as polylactic acid, polyglycolic acid, polydioxanone, polycapro lactone, copolymers of glycolide and trimethylene carbonate, polylactide/polyglycolide copo
- the polymer coating may be present in an amount from about 0.3% to about 10% by weight of the medical device, in embodiments from about 0.5% to about 5% by weight of the medical device, in other embodiments from about 0.7% to about 2.5% by weight of the medical device.
- the at least one masking agent, and any optional polymer in combination thereof may be combined with a solvent to form a coating solution or any combination thereof.
- a solvent to form such coating solution.
- Suitable solvents include, for example, alcohols, e.g., methanol, ethanol, and propanol; chlorinated hydrocarbons such as methylene chloride, chloroform, and 1,2-dichloro-ethane; and aliphatic hydrocarbons such as hexane, heptene, and ethyl acetate.
- heat may be applied to the solvent mixture to improve the solubility of the masking agent and any optional polymer. For example, temperatures from about 30 0 C to about 6O 0 C may be utilized in some cases.
- the at least one masking agent, as well as the at least one volatile dye can be applied to a medical device by any suitable process, e.g. passing the medical device through a solution, or past a brush or other coating solution applicator, or past one or more spray nozzles, or dipped directly into the at least one volatile dye and/or or at least one masking agent.
- the at least one masking agent, in combination with an optional coating material can be applied to the medical device to cover the entire medical device. In other embodiments, the at least one masking agent, in combination with an optional coating material, can be applied partially or intermittently to cover portions of the medical device to form a pattern thereon. It is envisioned that the masking agent and optional coating may be applied to the medical device in any fashion known for creating color patterns on devices, including the use of masks or ink-jet printing.
- the medical device may be treated to form a color pattern on the medical device.
- Suitable methods of treatment include, for example, heat-treating, increased pressurization, exposure to an inert gas such as nitrogen and combinations thereof.
- the treatment process may include a combination of methods, such as heat-treating the masked and dyed medical device under exposure to nitrogen.
- the treatment may include heating in a vacuum, which may be at a pressure of from about 50 m torr to about 700 torr.
- the masked and dyed medical device may be exposed to a temperature from about 75° C to about 175° C, in embodiments from about 100° C to about 150° C. In one embodiment, the masked and dyed medical device may be exposed to a temperature of about 12O 0 C.
- the time and temperature needed to treat the dyed medical device may vary depending upon the size of the medical device, as well as the amount of the at least one volatile dye or the at least one masking agent used to coat the device. Regardless of the treatment utilized, the medical device may be treated from about 10 minutes to about 24 hours, in embodiments from about 15 minutes to about 120 minutes, typically from about 30 minutes to about 60 minutes.
- the volatile nature of the dye causes the dye to be removed from the medical device in the areas of the medical device that do not contain the masking agent. These unmasked areas lose color and return to the natural color of the undyed medical device. However, the areas of the medical device that contain the masking agent retain their original color or experience a change in color thereby creating a colored pattern on the treated medical device.
- the color-patterned medical devices may further contain optional ingredients.
- optional ingredients include, but are not limited to, solvents, bioactive agents, lubricants, enrralsifiers, and fragrances. These optional ingredients may represent from about 0.01% to about 20% by weight of the color patterned medical device. In some embodiments, the optional ingredients may represent from about 0.1% to about 10% by weight of the medical device.
- the amount of the at least one volatile dye remaining in the dyed medical device after treatment in accordance with the methods of the present disclosure may be from about 0.01 % to about 5 % by weight of the medical device. In some embodiments from about 0.03 % to about 3 % by weight of the medical device, typically from about 0.05 % to about 1 % by weight of the medical device.
- a solvent may be used to remove excess masking agent from the dyed medical device after being treated as described above.
- suitable solvents include, but are not limited to, alcohols, e.g., methanol, ethanol, propanol, chlorinated hydrocarbons (such as methylene chloride, chloroform, 1,2- dichloro-ethane), and aliphatic hydrocarbons.
- braids coated with a higher level of calcium stearate appeared to bleach or change color at a slower rate than the uncoated or braids with less coating. Overall, most white streaks disappeared and the strongest blue color was obtained, especially for smaller sutures, after about 30 minutes to about 60 minutes of heating.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2007221316A AU2007221316B2 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
JP2008556405A JP2009527329A (en) | 2006-02-22 | 2007-02-22 | Medical device patterning method |
EP07751250.7A EP1991134A4 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
US12/160,933 US8092856B2 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
CA002637577A CA2637577A1 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
US13/314,399 US8202564B2 (en) | 2006-02-22 | 2011-12-08 | Method for patterning a medical device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77576706P | 2006-02-22 | 2006-02-22 | |
US60/775,767 | 2006-02-22 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/160,933 A-371-Of-International US8092856B2 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
US13/314,399 Continuation US8202564B2 (en) | 2006-02-22 | 2011-12-08 | Method for patterning a medical device |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007100575A2 true WO2007100575A2 (en) | 2007-09-07 |
WO2007100575A3 WO2007100575A3 (en) | 2008-07-31 |
Family
ID=38459526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/004478 WO2007100575A2 (en) | 2006-02-22 | 2007-02-22 | Method for patterning a medical device |
Country Status (6)
Country | Link |
---|---|
US (3) | US20070205910A1 (en) |
EP (1) | EP1991134A4 (en) |
JP (1) | JP2009527329A (en) |
AU (1) | AU2007221316B2 (en) |
CA (1) | CA2637577A1 (en) |
WO (1) | WO2007100575A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075020A1 (en) * | 2008-09-25 | 2010-03-25 | Tyco Healthcare Group Lp | Methods for coating filaments |
WO2013156293A1 (en) * | 2012-04-18 | 2013-10-24 | Itv Denkendorf Produktservice Gmbh | Composition, moulded article, thread, medical kit and medical product with improved degradation profile |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7589625B2 (en) * | 2005-12-20 | 2009-09-15 | General Electric Company | Wireless system with multi-device control |
US20070205910A1 (en) * | 2006-02-22 | 2007-09-06 | Parker-Hannifin Corporation | Wireless motion control system |
US20080150749A1 (en) * | 2006-12-21 | 2008-06-26 | Tai-Hung Lin | Wireless control system for controlling linear actuators |
WO2011090628A2 (en) * | 2009-12-29 | 2011-07-28 | Angiotech Pharmaceuticals, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
US9314244B2 (en) | 2013-12-20 | 2016-04-19 | Medos International Sarl | Directional surgical sutures |
CN107431451A (en) * | 2015-04-02 | 2017-12-01 | 雅吉多移动系统有限公司 | For moving the centralized network topology of related Control System |
EP3780644A4 (en) * | 2018-03-28 | 2021-03-24 | Sony Corporation | Information processing device, information processing system, information processing method, and information processing program |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4063878A (en) * | 1975-11-12 | 1977-12-20 | Minnesota Mining And Manufacturing Company | Applying sublimation indicia to pressure-sensitive adhesive tape |
DE3380420D1 (en) * | 1982-01-22 | 1989-09-21 | British Aerospace | Control apparatus |
JPH0634813B2 (en) * | 1986-12-05 | 1994-05-11 | 三井東圧化学株式会社 | Surgical bioabsorbable blue fiber and method for producing the same |
JPH01246050A (en) * | 1988-03-28 | 1989-10-02 | Fanuc Ltd | Machine position detecting device |
DE4304739C2 (en) * | 1993-02-13 | 1995-03-16 | Ethicon Gmbh | Surgical needle |
US5403347A (en) * | 1993-05-27 | 1995-04-04 | United States Surgical Corporation | Absorbable block copolymers and surgical articles fabricated therefrom |
EP0896855B1 (en) * | 1993-10-12 | 2003-02-26 | SMC Kabushiki Kaisha | Actuator |
US5573529A (en) * | 1994-10-31 | 1996-11-12 | Haak; Benjamin A. | Color coded medical instruments |
JPH09313494A (en) * | 1996-05-31 | 1997-12-09 | 嗣郎 ▲福▼島 | Thread for vascular suture |
JPH10306228A (en) * | 1997-03-07 | 1998-11-17 | Mitsubishi Chem Corp | Purification of dye and recording by using the purified dye |
US6203564B1 (en) * | 1998-02-26 | 2001-03-20 | United States Surgical | Braided polyester suture and implantable medical device |
US6235869B1 (en) * | 1998-10-20 | 2001-05-22 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
US20020156471A1 (en) * | 1999-03-09 | 2002-10-24 | Stern Roger A. | Method for treatment of tissue |
AU2002331786A1 (en) * | 2001-08-31 | 2003-03-18 | The Board Of Regents Of The University And Community College System, On Behalf Of The University Of | Coordinated joint motion control system |
DE10240976B4 (en) * | 2001-09-03 | 2005-07-07 | Smc K.K. | Sensor attachment for actuator body |
US6823221B2 (en) * | 2001-11-28 | 2004-11-23 | National Instruments Corporation | Motion control system and method which includes improved pulse placement for smoother operation |
JP3709393B2 (en) * | 2001-12-14 | 2005-10-26 | 富士ソフトエービーシ株式会社 | Remote control system and remote control method |
US20070014656A1 (en) * | 2002-07-11 | 2007-01-18 | Harris Randy A | End-effectors and associated control and guidance systems and methods |
KR20040038817A (en) * | 2002-11-01 | 2004-05-08 | 스미또모 가가꾸 고오교오 가부시끼가이샤 | Colored photosenstive resin composition and color filter comprising the same |
JP2004154877A (en) * | 2002-11-05 | 2004-06-03 | Japan Science & Technology Agency | Bending mechanism formed of multi-joint slider link |
US7415321B2 (en) * | 2002-12-12 | 2008-08-19 | Matsushita Electric Industrial Co., Ltd. | Robot controller |
EP1569562A4 (en) * | 2002-12-13 | 2010-11-03 | Tyco Healthcare | Antimicrobial fatty acid containing suture coating |
US7437201B2 (en) * | 2003-01-14 | 2008-10-14 | Cullen Christopher P | Electric motor controller |
US7023162B2 (en) * | 2003-02-18 | 2006-04-04 | The Chamberlain Group, Inc. | Automatic gate operator |
US6900608B2 (en) * | 2003-04-17 | 2005-05-31 | Automated Assemblies Corporation | Apparatus for controlling a motor |
WO2004096305A1 (en) * | 2003-04-29 | 2004-11-11 | The University Of Hong Kong | Coded surgical aids |
WO2004101017A2 (en) * | 2003-05-16 | 2004-11-25 | Blue Membranes Gmbh | Medical implants comprising biocompatible coatings |
US7091679B2 (en) * | 2004-02-19 | 2006-08-15 | Pacific Bearing Company | Magnetic thrust motor |
ES2372061T3 (en) * | 2004-11-01 | 2012-01-13 | Stryker Corporation | SAFE TRANSMISSION OF WIRELESS CONTROL TO A CENTRAL UNIT. |
US7904182B2 (en) * | 2005-06-08 | 2011-03-08 | Brooks Automation, Inc. | Scalable motion control system |
US20070205910A1 (en) * | 2006-02-22 | 2007-09-06 | Parker-Hannifin Corporation | Wireless motion control system |
JP4477029B2 (en) * | 2007-03-27 | 2010-06-09 | 株式会社東芝 | robot |
-
2007
- 2007-02-15 US US11/675,240 patent/US20070205910A1/en not_active Abandoned
- 2007-02-22 JP JP2008556405A patent/JP2009527329A/en active Pending
- 2007-02-22 AU AU2007221316A patent/AU2007221316B2/en not_active Ceased
- 2007-02-22 CA CA002637577A patent/CA2637577A1/en not_active Abandoned
- 2007-02-22 WO PCT/US2007/004478 patent/WO2007100575A2/en active Application Filing
- 2007-02-22 EP EP07751250.7A patent/EP1991134A4/en not_active Withdrawn
- 2007-02-22 US US12/160,933 patent/US8092856B2/en not_active Expired - Fee Related
-
2011
- 2011-12-08 US US13/314,399 patent/US8202564B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of EP1991134A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075020A1 (en) * | 2008-09-25 | 2010-03-25 | Tyco Healthcare Group Lp | Methods for coating filaments |
WO2013156293A1 (en) * | 2012-04-18 | 2013-10-24 | Itv Denkendorf Produktservice Gmbh | Composition, moulded article, thread, medical kit and medical product with improved degradation profile |
US10124086B2 (en) | 2012-04-18 | 2018-11-13 | Itv Denkendorf Produktservice Gmbh | Composition, molded article, thread, medical kit and medical product with improved degradation profile |
Also Published As
Publication number | Publication date |
---|---|
JP2009527329A (en) | 2009-07-30 |
AU2007221316B2 (en) | 2012-09-06 |
EP1991134A2 (en) | 2008-11-19 |
US20120073064A1 (en) | 2012-03-29 |
AU2007221316A1 (en) | 2007-09-07 |
US8202564B2 (en) | 2012-06-19 |
WO2007100575A3 (en) | 2008-07-31 |
US20090048627A1 (en) | 2009-02-19 |
US8092856B2 (en) | 2012-01-10 |
EP1991134A4 (en) | 2013-07-10 |
US20070205910A1 (en) | 2007-09-06 |
CA2637577A1 (en) | 2007-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8202564B2 (en) | Method for patterning a medical device | |
CA2499466C (en) | Antimicrobial fatty acid containing suture coating | |
EP2501300B1 (en) | Braided self-retaining sutures and methods | |
US6878757B2 (en) | Antimicrobial suture coating | |
CA1258410A (en) | Dry coating of surgical filaments | |
EP2028208B1 (en) | Phospholipid copolymers | |
JP2009106750A (en) | Filament-reinforced composite fiber | |
WO2012016035A1 (en) | Coated colored medical devices | |
JPS62183767A (en) | Coated suturing yarn | |
EP1214950A1 (en) | Surgical suture material, method of its manufacture and its use | |
JP2011031034A (en) | Coated filament | |
JPH09616A (en) | Suture for surgery with tip and its manufacture | |
DE60319038T2 (en) | Method of making suture having improved knot strength | |
KR20210146508A (en) | Filament having length indication and suture using the same | |
CA2499464A1 (en) | Method for making fast absorbing sutures by hydrolysis | |
EP1946705A2 (en) | Method for treating a section of a suture and forming a suture tip for attachment to a needle | |
KR0157510B1 (en) | Absorptive coating composition for surgical sutures and surgical sutures coated therewith | |
Aslan et al. | Comparison of different absorbable suture materials in skin closure: An experimental study in rats | |
EP1514517A1 (en) | Method for treating a section of a suture and forming a suture tip for attachment to a needle | |
WO1999043364A1 (en) | Absorbable copolymers and surgical articles fabricated thefefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 12160933 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007221316 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2637577 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2007221316 Country of ref document: AU Date of ref document: 20070222 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008556405 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007751250 Country of ref document: EP |